Market revenue in 2024 | USD 1,039.1 million |
Market revenue in 2030 | USD 3,084.0 million |
Growth rate | 19.9% (CAGR from 2024 to 2030) |
Largest segment | Upstream process |
Fastest growing segment | Downstream Process |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Upstream Process, Downstream Process, Process Development |
Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corp, Merck KGaA, Compagnie de Saint-Gobain SA, Corning Inc, Entegris Inc, Meissner, ProAnalytics, CellBios |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioprocess bags market will help companies and investors design strategic landscapes.
Upstream process was the largest segment with a revenue share of 44.41% in 2024. Horizon Databook has segmented the Asia Pacific bioprocess bags market based on upstream process, downstream process, process development covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific region is estimated to register the fastest growth rate during the projected period. The fast-paced growth of this region is expected to be mainly driven by China and India. Key factors driving the industry growth include an increase in access to technologies, a large patient pool, and improvement in healthcare infrastructure.
The increasing adoption of bioprocess bags in emerging markets by mature players to refine processes is also a significant factor driving the region’s growth. Moreover, the growing biotechnology sector, the presence of a large number of research & academic institutes, and significant investments by market participants are projected to drive the region’s market.
The presence of several government initiatives for immunization has led APAC manufacturers to focus on vaccine development and facilitate faster market entry. In addition, the growing demand for biologics due to improved safety and efficacy has fueled the R&D of biosimilar Monoclonal Antibodies (mAbs) in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific bioprocess bags market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific bioprocess bags market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account